(Q38920538)

7 September 2017

1 reference

title

Is Axonal Degeneration a Key Early Event in Parkinson's Disease? (English)

1 reference

7 September 2017

1 reference

5

Patrik Brundin

1 reference

7 September 2017

2

Jeffrey H Kordower

1 reference

7 September 2017

Zuzanna Kurowska

1

1 reference

7 September 2017

A Jon Stoessl

3

1 reference

7 September 2017

Robert E Burke

4

1 reference

7 September 2017

Zhenyu Yue

6

1 reference

7 September 2017

Scott T Brady

7

1 reference

7 September 2017

Jeffrey Milbrandt

8

1 reference

7 September 2017

Bruce D Trapp

9

1 reference

7 September 2017

Todd B Sherer

10

1 reference

7 September 2017

Satish Medicetty

11

1 reference

7 September 2017

publication date

4 August 2016

1 reference

Journal of Parkinson's disease

7 September 2017

published in

1 reference

7 September 2017

volume

6

1 reference

7 September 2017

issue

4

1 reference

7 September 2017

page(s)

703-707

1 reference

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Dopamine turnover increases in asymptomatic LRRK2 mutations carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Retrograde Axonal Degeneration in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Engrailed Homeoprotein Protects Mesencephalic Dopaminergic Neurons from Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Engrailed homeoprotein recruits the adenosine A1 receptor to potentiate ephrin A5 function in retinal growth cones.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

1-Methyl-4-phenylpyridinium induces synaptic dysfunction through a pathway involving caspase and PKCdelta enzymatic activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

SARM1 activation triggers axon degeneration locally via NAD⁺ destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJPD-160881

21 January 2018

Identifiers

DOI

10.3233/JPD-160881

0 references

1 reference